A phase II dose-ranging study of topical resiquimod to treat actinic keratosis
Article
Szeimies, R.-M., Bichel, J., Ortonne, J.-P., Stockfleth, E., Lee, J. and Meng, T-C. (2008) A phase II dose-ranging study of topical resiquimod to treat actinic keratosis. British Journal of Dermatology 159 (1), pp. 205-210.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | British Journal of Dermatology | ||||
| Publisher | WILEY-BLACKWELL | ||||
| Place of Publication | MALDEN | ||||
| Volume | 159 | ||||
| Number of Issue or Book Chapter | 1 | ||||
| Page Range | pp. 205-210 | ||||
| Date | 2008 | ||||
| Date of publication | 19 Dec 2024 13:15 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | IMIQUIMOD 5-PERCENT CREAM; SQUAMOUS-CELL CARCINOMA; DOUBLE-BLIND; DENDRITIC CELLS; 2 COURSES; TLR7; EFFICACY; AGONISTS; SAFETY; TRIAL; actinic keratosis; imidazoles; immunotherapy; toll-like receptor | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 67999 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric